Laboratories seeking to optimize their antibody discovery processes can now leverage the Opentrons Flex® neoSwitch™ Workstation. Developed by Opentrons Labworks, Inc. in collaboration with Neochromosome, Inc., this platform automates essential steps in the antibody discovery workflow, including binder purification and characterization.
The neoSwitch system's ability to switch between yeast surface display and protein secretion modes streamlines the discovery process, reducing the need for manual interventions and minimizing errors. By automating these processes, laboratories can achieve faster results, better throughput, and fewer bottlenecks.
Benefits for laboratory managers
- Reduces reliance on external CROs, offering greater control over research timelines
- Minimizes manual labor, allowing staff to focus on strategic tasks
- Enhances reproducibility and consistency in experimental results
- Accelerates the identification of promising antibody candidates
- Provides a scalable solution adaptable to various throughput needs
Implementing the Opentrons Flex neoSwitch Workstation can lead to significant time and cost savings, making it a valuable addition to modern laboratories aiming for efficiency and innovation.
This article has been sourced from a press release and may include content created or refined using AI tools and verified by our editorial team. For the full press release, visit: "Neochromosome and Opentrons Introduce Automated Antibody Discovery Solution, Enabling Labs to Achieve Rapid, Cost-Effective In-House Development."
